Are ghrelin receptor gene polymorphisms associated with female metabolic syndrome in Chinese population?
The polymorphisms within GHSR might be a genetic risk factor for metabolic syndrome in women.
The presence of KRAS mutation did not correlate with the various clinicopathological factors of CRC patients or the survival rate. However, the survival rate was reduced in BRAF-mutated CRC patients. Therefore, BRAF mutation could be an important prognostic factor in CRC patients.